Skip to main content
Clinical Trials/ISRCTN63231313
ISRCTN63231313
Active, Not Recruiting
Phase 3

Remote Ischaemic Conditioning After Stroke Trial (ReCAST- 3)

niversity of Nottingham0 sites1,300 target enrollmentApril 20, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Adults with acute ischaemic stroke presenting in Emergency Departments and Stroke Units in the UK
Sponsor
niversity of Nottingham
Enrollment
1300
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2020
End Date
September 30, 2026
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Nottingham

Eligibility Criteria

Inclusion Criteria

  • Current participant inclusion criteria as of 20/12/2023:
  • 1\. Hyperacute ischaemic stroke
  • 2\. \< 24h post stroke onset
  • 3\. Primary intracerebral haemorrhage ruled out on baseline clinical neuroimaging
  • 4\. NIHSS score of 5\-25 at randomisation
  • 5\. Aged 18 years or above
  • Previous participant inclusion criteria as of 29/04/2020 to 20/12/2023:
  • 1\. Hyperacute ischaemic stroke
  • 2\. \< 6 h post stroke onset
  • 3\. Primary intracerebral haemorrhage ruled out on baseline clinical neuroimaging

Exclusion Criteria

  • Current participant exclusion criteria as of 20/12/2023:
  • 1\. Pre\-morbid dependency (modified Rankin Scale, mRS\>3\)
  • 2\. Systolic BP \=80 mmHg
  • 3\. Spontaneous intracerebral haemorrhage
  • 4\. Haemorrhagic transformation of infarction PH2 if known before randomisation (not excluded or withdrawn if occurs after randomisation)
  • 5\. Dementia \- if the patient had a pre\-existing diagnosis
  • 6\. Coma (GCS \<8\)
  • 7\. Malignancy and significant co\-morbidity (life expectancy \<6 months)
  • 8\. BM \<3\.0 mmol/L
  • 9\. Seizure on presentation unless brain imaging identifies evidence of significant brain ischaemia

Outcomes

Primary Outcomes

Not specified

Similar Trials